About Us
Candesant Biomedical
Candesant Biomedical is focused on development of a novel treatment for the non-invasive treatment of excessive sweating or hyperhidrosis.
The company’s lead product is a topical patch to conveniently treat excessive sweating with a quick, in-office procedure.
Two successful clinical studies demonstrated efficacy in reducing sweat and validated that the energy is reproducibly generated, highly targeted and appears to inactivate the most active sweat glands.
In these initial clinical studies, Candesant’s treatment demonstrated significant sweat reduction benefits lasting up to 3-4 months after a single, no down-time treatment.
Leadership
Candesant is led by a deeply experienced team of drug and device development professionals passionate about meeting real patient and physician needs.
Niquette Hunt
Founder and CEO
Niqui has over 25 years experience in developing, launching and commercially scaling 20+ products.
Niquette Hunt
Mary Beth Kreissler
Chief Financial Officer
Mary Beth has 20 years’ experience with pre-revenue and early commercialization stage companies in tech and life sciences.
Mary Beth Kreissler
Angela Boyd
Chief Commercial Officer
Angela has more than 25 years experience developing and launching products in the dermatology/aesthetics space.
Angela Boyd
Erica Bazerkanian
SVP Marketing
Erica Bazerkanian has 25 years’ experience in commercial strategy, new product development and market creation.
Erica Bazerkanian
Jesse Rosen
VP Product Development
Jesse has 20+ years of experience in the design, development and manufacturing of medical devices.
Jesse Rosen
Erin Tims
VP Clinical Affairs
Erin has 15 years experience in the design and execution of clinical studies across various therapeutic categories.
Erin Tims
Scott Wilson
Head, Regulatory Affairs
Scott has over 25 years' experience in the medical device industry, specializing in regulatory affairs and quality.
Scott Wilson
In Remembrance
Jacob Waugh, MD
Co-Founder, Inventor of the TAT Technology
Jacob Waugh, a prolific inventor who left behind 40+ issued and 300+ pending patents, dedicated his life to scientific innovation and development.
Jacob Waugh, MD
Board of Directors
Samara Braunstein
Samara Braunstein is a marketing and financial professional with decades of experience in healthcare, consumer products, and finance.
Samara Braunstein
Eric Compton
Eric Compton is a seasoned executive and business leader with a proven track record of success in the Medical Device, Diagnostics and Consumer Packaged Goods industries.
Eric Compton
Brad Hauser
Brad Hauser is a seasoned aesthetics leader with experience managing R&D, operations and commercial teams.
Brad Hauser
Niquette Hunt
Niqui has over 25 years experience in developing, launching and commercially scaling 20+ products.
Niquette Hunt
Michael Kane, MD
Michael Kane, MD is an aesthetic plastic surgeon and entrepreneur who has been practicing in New York City for more than 25 years.
Michael Kane, MD
Michael is an aesthetic plastic surgeon and entrepreneur who has been practicing in New York City for more than 25 years. Dr. Kane performs a wide variety of cutting-edge cosmetic surgical procedures, facial rejuvenation, and cosmetic injections. Dr. Kane has been in private practice since 1992 and frequently lectures on topics relating to aesthetic plastic surgery and aesthetic medicine. Dr. Kane completed his college and medical school studies in only five years at the combined Pennsylvania State University/Jefferson Medical College program. At Jefferson, Dr. Kane was a member of the Hobart Hare Honor Society. Dr. Kane completed a general surgery residency at New York Medical College and then a plastic surgical residency at Wright State University, Dr. Kane then completed an additional fellowship in aesthetic surgery at New York University, based at the Manhattan Eye, Ear & Throat Hospital. Dr. Kane is known for his work with botulinum toxin A. He pioneered the use of Botulinum for cosmetic purposes while a fellow at the Manhattan Eye, Ear & Throat Hospital. Over the past 25 years, Dr. Kane has taught thousands of physicians how to properly inject botulinum toxin and fillers through lectures and live demonstrations. Dr. Kane is also an authority on correcting the tear trough and periorbital area using fillers. He authored the first scientific paper on this technique, and continues to lecture worldwide on the subject. Dr. Kane has over one thousand scientific presentations around the globe. His original work has appeared in Plastic and Reconstructive Surgery, the Aesthetic Surgery Journal, Aesthetic Plastic Surgery, Dermatologic Surgery, the Journal of Drugs in Dermatology, the Journal of Cosmetic Laser Therapy, Facial Plastic Surgery, and Ophthalmic Plastic and Reconstructive Surgery. He launched the award-winning Serum Savant skin care line in 2015. He serves as a consultant to nearly all of the major aesthetics companies. He has written many textbook chapters and three books.
Ellie McGuire
Ellie McGuire is a partner of the LS Polaris Innovation Fund. McGuire currently serves on the Boards of Montis Biosciences and Mellitus.
Ellie McGuire
Susan Stimson
With over 25 years’ experience in the medical device and pharmaceutical sectors, Susan is an accomplished executive in development and commercialization of new medical technologies at both start-ups and large public companies.